Heyer Investment Management LLC filed a Form 144 notice on November 2, 2026, disclosing a proposed sale of 20,000 shares of OneSpaWorld Holdings Limited common stock on NASDAQ, with an aggregate market value of $604,400.00.
Michael George Rosenbaum, Chief Executive Officer and Director of Guidewire Software, Inc., filed a Form 4 on November 2, 2026, reporting the sale of 1,200 shares of common stock on that same date.
FedEx Corp officer Gina F. Adams filed a Form 144 notice of proposed sale of 3,014 shares of FedEx common stock, with an approximate sale date of November 2, 2026, through Merrill Lynch, Pierce, Fenner & Smith Inc.
Matthew Kirk, Chief Financial Officer of AXIS Capital Holdings Limited, filed a Form 4 on November 2, 2026, disclosing the disposal of 1,063 common shares on November 1, 2026, at a price of $104.87 per share.
Director Henry B. Smith filed a Form 4 with the SEC on November 2, 2026, disclosing the sale of 4,893 common shares of AXIS Capital Holdings Limited on that same date.
Summit Midstream Corporation filed an 8-K on November 2, 2026, announcing it will report third-quarter 2026 operating and financial results on November 9, 2026, after the close of trading, and will host an earnings conference call the following morning.
Hampton Financial Corp. and its CEO Peter M. Deeb filed an amended beneficial ownership statement with the SEC on November 2, 2026, disclosing that Hampton sent a letter to Icon Energy Corp on October 29, 2026, and reporting a 9.0% stake in the company's …
i-80 Gold Corp. reported its financial and operating results for the three and nine months ended September 30, 2026, disclosing a net loss of $48.4 million, revenues of $32.7 million, and cash of $411.4 million, alongside development updates across its Nevada gold portfolio.
The Highland Opportunities and Income Fund announced its regular monthly common stock distribution of $0.0385 per share, payable November 30, 2026, to shareholders of record as of November 23, 2026.
RA Capital Management, L.P. and affiliated reporting persons filed a Form 4 on November 2, 2026, disclosing the sale of approximately 2.718 million shares of LENZ Therapeutics, Inc. common stock on October 29, 2026.